These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 642610)
1. The Committee on Drugs. Yaffe K Md State Med J; 1978 Apr; 27(4):57-9. PubMed ID: 642610 [No Abstract] [Full Text] [Related]
2. Role of the Baltimore City Medical Society in drug use and abuse in Maryland. Pachuta DM Md State Med J; 1973 Mar; 22(3):81-2. PubMed ID: 4734675 [No Abstract] [Full Text] [Related]
3. The control of drugs and therapeutic freedom. Dunlop D Proc R Soc Med; 1968 Aug; 61(8):841-6. PubMed ID: 5695368 [No Abstract] [Full Text] [Related]
4. Recent activities of the medical and chirurgical faculty in the control of drug abuse. Berman JI Md State Med J; 1973 Mar; 22(3):82-3. PubMed ID: 4688953 [No Abstract] [Full Text] [Related]
5. [Are the adverse effects over-emphasised in discussions on drugs?]. Liljestrand A Nord Med; 1976 Sep; 91(8-9):213-5. PubMed ID: 967646 [No Abstract] [Full Text] [Related]
6. [Drugs]. Greppin R Z Krankenpfl; 1972 Dec; 65(12):446-51. PubMed ID: 4486551 [No Abstract] [Full Text] [Related]
7. [Tasks of the Commission on Drugs of the German Medical Association in introducing new psychopharmacologic agents]. Janz HW Med Klin; 1971 Nov; 66(48):1661-5. PubMed ID: 5134364 [No Abstract] [Full Text] [Related]
8. Control listings ... narcotic and controlled drugs. Burnie CF Can Hosp; 1968 Mar; 45(3):39-45. PubMed ID: 5642767 [No Abstract] [Full Text] [Related]
9. Report of the Food and Drugs sub-committee of the Ceylon Medical Association on the import and manufacture of pharmaceuticals in Ceylon--comments on the Wickremasinghe-Bibile report. Ceylon Med J; 1971 Jun; 16(2):122-3. PubMed ID: 5163547 [No Abstract] [Full Text] [Related]
10. [Physicians' influence on the "drug market"]. Paprocki M Pol Tyg Lek; 1982 Jun; 37(19-20):585-7. PubMed ID: 7177953 [No Abstract] [Full Text] [Related]
11. [Definition of the drug given in 1969 by a committee of WHO experts]. Quevauviller A; Mabileau J; Vaille C Ann Pharm Fr; 1969 Jun; 27(6):403-9. PubMed ID: 5392371 [No Abstract] [Full Text] [Related]
12. WHO Expert Committee on Specifications for Pharmaceutical Preparations. 22. World Health Organ Tech Rep Ser; 1969; 418():1-29. PubMed ID: 4980004 [No Abstract] [Full Text] [Related]
13. [The Medical Products Agency's preparations prior to the new EU regulation on children and drugs]. Johannesson M; Berglund EG Lakartidningen; 2007 Jul 11-24; 104(28-29):2099. PubMed ID: 17702388 [No Abstract] [Full Text] [Related]
15. Drugs and the Washington climate. Durant TM Trans Am Clin Climatol Assoc; 1969; 80():196-204. PubMed ID: 4896316 [No Abstract] [Full Text] [Related]
17. Quality control of drugs: certification scheme on the quality of pharmaceutical products moving in international commerce. WHO Chron; 1980 Nov; 34(11):427-32. PubMed ID: 7467274 [No Abstract] [Full Text] [Related]
18. [Control and safeguarding of drugs]. Kuemmerle HP Int J Clin Pharmacol; 1972 Aug; 6(3):207-8. PubMed ID: 4648463 [No Abstract] [Full Text] [Related]
19. [Criteria for choice of preparations in a drug committee]. Lunde PK Tidsskr Nor Laegeforen; 1975 Jan; 95(1):37-40. PubMed ID: 1111161 [No Abstract] [Full Text] [Related]
20. Veterinary drug availability. Gloyd J J Am Vet Med Assoc; 1980 Apr; 176(7):611-4. PubMed ID: 7372533 [No Abstract] [Full Text] [Related] [Next] [New Search]